Affiliation:
1. Department of Liver Diseases, The Third People's Hospital of Shenzhen The Second Affiliated Hospital of Southern University of Science and Technology Shenzhen Guangdong China
2. Department of Pathology, The Third People's Hospital of Shenzhen The Second Affiliated Hospital of Southern University of Science and Technology Shenzhen Guangdong China
Abstract
AbstractLimited data exist regarding the association between hepatitis B virus (HBV) DNA levels and liver histopathological changes in patients with chronic hepatitis B (CHB) during the immune tolerant (IT) phase. In this study, we retrospectively analysed liver biopsy results from 150 adult IT‐CHB patients. The liver tissue necroinflammation and fibrosis were evaluated by the Scheuer scoring system. Multivariate logistic regression, smooth curve fitting, and segmented regression models were used to examine the association between HBV DNA levels and liver histopathological changes. A total of 26%, 30.67% and 42% of IT patients had significant necroinflammation (≥G2), significant fibrosis (≥S2) and significant histopathological changes (≥G2 and/or ≥S2), respectively. HBV DNA levels were independently and non‐linear inversely associated with significant necroinflammation and histopathological changes in IT‐CHB patients. Patients with HBV DNA levels <107 IU/mL had a higher risk of significant histopathological changes compared to those with levels >107 IU/mL. The findings were further confirmed by smooth curve fitting analyses, subgroup and sensitivity analyses. In segmented regression model analyses, the optimal DNA value for the lowest odds ratio of significant histopathological changes was 7.26 log10 IU/mL. A non‐linear inverse association between HBV DNA levels and significant histopathological changes in IT‐CHB patients. DNA 7.26 log10 IU/mL may serve as a potential cut‐off point to define a ‘true immune tolerant phase’ with minimal liver histopathological changes.